Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Korea Stock Exchange  >  SK Holdings Co., Ltd    A034730   KR7034730002

SK HOLDINGS CO., LTD

(A034730)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

SK Biopharmaceuticals prices at top of range for South Korea's biggest IPO in three years

06/19/2020 | 04:48am EST

Drugmaker SK Biopharmaceuticals Co Ltd priced its initial public offering on Friday at the top of its indicative range, aiming to raise 959 billion won ($794 million) in South Korea's biggest IPO in three years.

SK Biopharmaceuticals in November became the first South Korean company to receive U.S. Food and Drug Administration approval for an independently developed drug, called Xcopri, which is a treatment for epilepsy.

The drugmaker seeks to revive an IPO market hit by geopolitical concerns and fears of another outbreak of COVID-19.

SK Biopharmaceuticals' shares priced at 49,000 won, the top end of a range of 36,000-49,000 won per share indicated in a regulatory filing earlier this month.

The pricing values the company at 3.8 trillion won.

It will be the largest IPO in Seoul since Celltrion Healthcare raised 1 trillion won in its offering in July 2017.

SK Holdings Co Ltd will own 75% of the company after listing, expected on July 2.

(Reporting by Joyce Lee; Editing by Jan Harvey and Susan Fenton)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
CELLTRION HEALTHCARE CO LTD End-of-day quote.
CELLTRION, INC. -6.67% 329000 End-of-day quote.-8.36%
SK HOLDINGS CO., LTD -1.14% 302500 End-of-day quote.25.78%
All news about SK HOLDINGS CO., LTD
01/08MARKET CHATTER : SK Group to Invest $1.5 Billion in US Hydrogen Fuel Cell Manufa..
MT
01/07MARKET CHATTER : Korea's Commerce, Industry Chamber Set to Tap SK Chairman as Ch..
MT
01/06South Korea's SK Group to invest $1.5 bln in fuel cell maker Plug Power
RE
01/05SK BIOPHARMACEUTICALS : to sell Arvelle Therapeutics stake to Angelini Pharma
AQ
2020MARKET CHATTER : South Korea's Big Four Tech Firm Bosses Richer than its Four Ch..
MT
2020WHERE WATER TURNS TO SNOW : S.Korean ultra-cold warehouse prepares to store Pfiz..
RE
2020MARKET CHATTER : SK Holdings Invests $200 Million in Roivant Sciences' Platform ..
MT
2020MARKET CHATTER : SK Holdings Establishes Hydrogen Business Team
MT
2020MARKET CHATTER : SK Group-Led "Happiness Alliance" Now has More than 100 Member ..
MT
2020SK Biopharmaceuticals and LifeSci Venture Partners Forge Ties for Open Innova..
AQ
More news
Financials
Sales 2020 84 847 B 77,0 B 77,0 B
Net income 2020 426 B 0,39 B 0,39 B
Net Debt 2020 38 779 B 35,2 B 35,2 B
P/E ratio 2020 49,8x
Yield 2020 1,87%
Capitalization 15 822 B 14 349 M 14 351 M
EV / Sales 2020 187x
EV / Sales 2021 175x
Nbr of Employees 4 264
Free-Float 44,8%
Chart SK HOLDINGS CO., LTD
Duration : Period :
SK Holdings Co., Ltd Technical Analysis Chart | A034730 | KR7034730002 | MarketScreener
Technical analysis trends SK HOLDINGS CO., LTD
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Average target price 333 200,00 KRW
Last Close Price 302 500,00 KRW
Spread / Highest target 48,8%
Spread / Average Target 10,1%
Spread / Lowest Target -12,4%
EPS Revisions
Managers and Directors
NameTitle
Tae-Won Chey Chairman & Co-Chief Executive Officer
Dong-Hyun Jang President, Co-Chief Executive Officer & Director
Jung-Ho Park Co-President & Co-Chief Executive Officer
Jae-Ho Yeom Chairman
Eui-Dong Jang Executive Board Member & Head-Finance
Sector and Competitors
1st jan.Capitalization (M$)
SK HOLDINGS CO., LTD25.78%14 349
EXXON MOBIL CORPORATION16.18%202 490
RELIANCE INDUSTRIES LTD-2.41%168 168
BP PLC18.70%83 090
CHINA PETROLEUM & CHEMICAL CORPORATION14.70%75 625
NESTE OYJ2.13%56 091